How to sell Shield AI shares

Start with what you hold

Employees and former employees typically hold some mix of settled RSU shares, unexercised options and unsettled RSUs; early investors and angels hold preferred or common bought directly or through a fund. The distinctions decide everything: shares you own can be sold where the company’s rules permit; unexercised options and unsettled RSUs generally cannot move on their own. Pull your grant documents and your equity-portal statement before talking to anyone — including us. What your position can do is a document question, not an opinion.

How Shield AI liquidity actually works

Shield AI restricts transfers the way venture-backed companies do — company approval and typically a right of first refusal stand between a priced buyer and a closed trade — and it has published no void-transfer warning of the kind the AI labs have. The record shows a working market: of the Shield AI secondary trades recorded on PrivateMarketView, the structures split between SPVs and consented direct transfers, with the occasional forward — direct transfers on the ledger mean the company does approve sales it is comfortable with. What is particular to a defense name is the second gate: who the buyer is matters. Expect screening for foreign ownership, control or influence concerns before any transfer is blessed. A credible sale starts from the documents, the consent and an eligible buyer — not from a price.

What the stock is worth

The anchors are recent and public: the March 2026 round raised $2 billion at a $12.7 billion valuation — co-led by Advent with JPMorgan’s strategic investment group, and Blackstone funds adding preferred equity — and September 2026 reporting put the company in talks at a materially higher valuation, which remains reporting until a round closes. The live numbers — the current mark, the full round history, trade aggregates and the investor book — are maintained on the Shield AI data page, published from PrivateMarketView, the data platform behind this site. None of those references is your price: a block of Shield AI prices on its specifics — share class, size, structure, buyer eligibility — and that number comes from buyers, not from a chart.

The next-round question

Shield AI has made no IPO filing; the live question for holders is the reported round talks at a higher valuation. Reported talks are not money: rounds in negotiation re-price, shrink or die, and a secondary sale today prices on what buyers will pay now, not on a headline. That leaves three honest positions: wait for the round and accept the risk it closes lower or not at all; sell now at a negotiated price; or the middle path, selling part now and keeping the rest for the re-price. Which is right turns on your own concentration, cash needs and tax position — it is the one question on this page a desk should inform and never answer for you.

How a sale runs through this desk

Tell the desk what you hold — class, rough size, exercised or not — and your timing. We confirm what your position can do under the company’s rules first, which for Shield AI includes scoping buyer eligibility early. The position then goes to buyers without your name on it; defense autonomy is a sector with standing demand, and indications on clean files usually come back within a business day. You are not named until you agree to proceed, there is no fee to ask, and the fee on a brokered block is quoted on your file in writing — how the fee works. The close runs through a FINRA-registered broker-dealer; our CRDs are on the about page.

Common questions

Can I sell my Shield AI shares?

Often, yes — within the company’s process. Shield AI stock carries the standard private-company controls: transfers need company approval and typically face a right of first refusal. The record shows consented sales do close here — recorded Shield AI secondaries include direct transfers alongside SPV trades — so the routes are real. The first step on any file is confirming what your specific holding — common, RSUs settled or not, options exercised or not — can do under your grant documents.

Can I sell unexercised Shield AI options or unsettled RSUs?

Unexercised options are personal and do not transfer; the usual solutions are exercising at close with the proceeds or a forward-style structure, depending on what the company’s documents permit. RSUs that have not settled into shares are promises, not stock, and generally cannot be sold. Shares you actually hold are where the routes open up.

Does being a defense company change who can buy my shares?

Yes, in practice. A defense contractor’s cap table is a national-security matter: companies in this position typically screen buyers for foreign ownership, control or influence concerns, and a transfer to the wrong buyer can raise regulatory review the company will not risk. That narrows the buyer pool to U.S. institutional and accredited money for most files — which is the pool a desk works anyway. Expect buyer eligibility to be part of diligence, not a surprise at the end.

What is Shield AI stock worth right now?

The live reference points are the March 2026 round — $2 billion raised at a $12.7 billion valuation, led by Advent with JPMorgan’s strategic group and Blackstone participating — and reporting from September 2026 that the company was in talks at a materially higher valuation, unconfirmed until a round closes. The live numbers — the current mark, round history, trade aggregates and the investor book — are maintained on the Shield AI data page, published from PrivateMarketView, the data platform behind this site. None of those references is your price: a real indication for your block comes from taking it to buyers.

Should I wait for the next round or an IPO instead of selling?

That is a real option with real costs. Reported talks at a higher valuation are not a closed round, and Shield AI has made no IPO filing; nothing is certain until money moves. Selling into a rising reported mark means leaving some upside if the round closes — and avoiding the risk that it does not. The middle path many holders take: sell part now at a negotiated price, keep the rest. The right split depends on your concentration and your taxes, not on anyone’s forecast.

Will Shield AI know I am selling?

If the trade touches the company’s process — approval, the ROFR, a transfer on the ledger — eventually yes, as at any private company; at a defense name the company’s interest in who holds its stock is stronger than most. What a careful process controls is when and to whom you are named: not to buyers until you agree to proceed, and not to anyone as a shopping exercise. Structures that lean on the company never finding out are a warning sign, not a route.

Premier Alternatives is not affiliated with Shield AI. This page describes public information and market behavior as of October 26, 2026; it is not legal, tax or investment advice, and a sale of private shares deserves an hour with your tax adviser before it closes.

Read next

• The Shield AI data page — valuation, rounds, trade aggregates, the investor book.
• How to sell Anduril shares — the other defense name, written to its open tender.
• Direct transfer, SPV or forward — why the structure matters, and the all-in number to ask for.
• The process, step by step — the eight steps of any private-share sale.
• Every route to liquidity, compared — tender, broker, marketplace, forward, or wait.